FI48975B - - Google Patents

Info

Publication number
FI48975B
FI48975B FI01280/67A FI128067A FI48975B FI 48975 B FI48975 B FI 48975B FI 01280/67 A FI01280/67 A FI 01280/67A FI 128067 A FI128067 A FI 128067A FI 48975 B FI48975 B FI 48975B
Authority
FI
Finland
Application number
FI01280/67A
Other languages
Finnish (fi)
Other versions
FI48975C (fi
Inventor
H Klaeui
W Rehm
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of FI48975B publication Critical patent/FI48975B/fi
Publication of FI48975C publication Critical patent/FI48975C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electric Connection Of Electric Components To Printed Circuits (AREA)
  • Medicinal Preparation (AREA)
FI671280A 1966-05-09 1967-05-03 Menetelmä sulfonamidien ja sulfonamidipotentiaattorien injektoitavan s eoksen valmistamiseksi. FI48975C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671666 1966-05-09

Publications (2)

Publication Number Publication Date
FI48975B true FI48975B (de) 1974-12-02
FI48975C FI48975C (fi) 1975-03-10

Family

ID=74187416

Family Applications (1)

Application Number Title Priority Date Filing Date
FI671280A FI48975C (fi) 1966-05-09 1967-05-03 Menetelmä sulfonamidien ja sulfonamidipotentiaattorien injektoitavan s eoksen valmistamiseksi.

Country Status (16)

Country Link
US (1) US3551564A (de)
JP (1) JPS5017524B1 (de)
BE (1) BE698102A (de)
CH (1) CH544053A (de)
DE (1) DE1617521C3 (de)
DK (1) DK117520B (de)
ES (1) ES340262A1 (de)
FI (1) FI48975C (de)
FR (1) FR1523606A (de)
GB (1) GB1176395A (de)
GR (1) GR35814B (de)
IL (1) IL27876A (de)
IT (1) IT1143624B (de)
NL (1) NL140736B (de)
NO (1) NO127486B (de)
SE (1) SE348112B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM3271A1 (en) * 1970-03-13 1972-10-23 Wellcome Found Improvements in or relating to injectable therapeutic compositions
US3728452A (en) * 1971-01-20 1973-04-17 Abic Ltd Water-soluble composition comprising sulfadimidine and pyrimethamine
IT1044231B (it) * 1972-03-16 1980-03-20 Hoffmann La Roche Combinazione di sostanze attive utile per combattere infezioni da batteri gram positivi e gran negativi
DE2342213C3 (de) * 1972-10-12 1979-10-18 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Verwendung von potenzierten SuIf onamiden bei der Behandlung oder Verhinderung von Fischinfektionen
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1485383A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable non-aqueous therapeutic compositions
GB1485382A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable therapeutic compositions
US4039543A (en) * 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631780C3 (de) * 1976-07-15 1981-11-19 Basf Ag, 6700 Ludwigshafen Sulfonamid-Trimethoprim-Lösungen
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
MC1264A1 (fr) * 1978-05-24 1980-03-28 Wellcome Found Procede de preparation de benzylpyrimides et de medicaments contenant ces substances
DE2963408D1 (en) 1978-08-01 1982-09-16 Ciba Geigy Ag Stable medicinal solution on the basis of 2,6-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine(trimethoprim) and a sulphonamide, process for preparing and using it
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
HU180740B (en) * 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions

Also Published As

Publication number Publication date
DE1617521A1 (de) 1972-02-10
FR1523606A (fr) 1968-05-03
FI48975C (fi) 1975-03-10
DE1617521B2 (de) 1979-01-04
JPS5017524B1 (de) 1975-06-21
NL6706474A (de) 1967-11-10
GR35814B (el) 1968-11-04
NL140736B (nl) 1974-01-15
CH544053A (de) 1973-11-15
ES340262A1 (es) 1968-06-01
GB1176395A (en) 1970-01-01
NO127486B (de) 1973-07-02
IT1143624B (it) 1986-10-22
DE1617521C3 (de) 1979-09-06
DK117520B (da) 1970-05-04
SE348112B (de) 1972-08-28
BE698102A (de) 1967-11-08
US3551564A (en) 1970-12-29
IL27876A (en) 1971-10-20

Similar Documents

Publication Publication Date Title
AT281852B (de)
AU5917865A (de)
AU428063B2 (de)
AU424443B2 (de)
AU414526B2 (de)
AU433222B2 (de)
AU421822B2 (de)
AU417216B2 (de)
AU415165B1 (de)
AU1111066A (de)
AU6703465A (de)
AU612166A (de)
AU5895065A (de)
AU218666A (de)
AU1144366A (de)
BE447356A (de)
BE618801A (de)
AU407778B2 (de)
AU414093B2 (de)
AU415780B2 (de)
BE675084A (de)
AU411645B2 (de)
AU6852465A (de)
AU855865A (de)
AU92366A (de)